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OBJECTIVES: Iatrogenic chronic pain is increasingly recognized
as a major adverse outcome after inguinal hernia repair. In order
to assess chronic post-herniorrhaphy pain, we developed the 18-
item Inguinal Pain Questionnaire (IPQ). The aim of the present
study was to test its validity and reliability and explore the preva-
lence of long term pain as determined by the questionnaire in a
sample from the population-based Swedish Hernia Register.
METHODS: Validity was tested in 100 patients who received
the IPQ and the Brief Pain Inventory (BPI) 1 and 4 weeks after
surgery (Group A). The reliability was tested in 100 patients who
received the IPQ on two occasions one month apart 3 years after
operation (Group B). From the Swedish Hernia Register 2853
operated 2000 were requested to ﬁll in IPQ by mail. RESULTS:
As an indication of construct validity, a signiﬁcant (p < 0.001)
decrease in IPQ-rated pain intensity was observed in the ﬁrst 4
weeks after surgery. Signiﬁcant (p < 0.05) correlations with cor-
responding BPI pain intensity items corroborated the criterion
validity. The rate of logical incoherence did not exceed 5.5% for
any item. Kappa values in the test-retest one month apart in
group B were higher than 0.5 for all but three items, indicating
acceptable reliability. Cronbachs alpha was 0.83 for questions
on pain intensity and 0.51 for interference with daily activities.
After two reminders, 2456 patients (86%), in the sample from
the Hernia Register had responded to the questionnaire. In
response to a question about “worst perceived pain last week”,
758 patients (31%) reported pain to some extent. In 144 cases
(6%) the pain interfered with daily activities. CONCLUSION:
The validity and reliability is sufﬁcient to make IPQ a useful
instrument in the routine assessment of post-herniorrhaphy pain.
Disabling pain was found to be a widespread problem 3 years
after surgery.
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OBJECTIVES: Asthma and chronic obstructive pulmonary
disease (COPD) present health concerns and an economic burden
for patients and managed care plans. This study compares uti-
lization outcomes in patients with COPD, asthma or co-
occurring COPD and asthma in a Medicaid population.
METHODS: We queried all medical and pharmacy claims of
Medicaid patients with COPD and/or asthma ﬁled between
January 1, 20001 and December 31, 2003, from encounter data.
COPD patients were identiﬁed based on at least one claim with
ICD-9 codes 491, 492, 496, and asthma patients on the basis of
ICD-9 code 493 as primary, secondary or tertiary diagnosis. We
analyzed annual utilization attributable to COPD and/or asthma,
and compared relative utilization of hospitalizations, physician,
outpatient and emergency room visits as well as drug prescrip-
tions. RESULTS: The analysis included a total of 3455 COPD,
3072 asthma and 2604 COPD/asthma patients, and showed 
statistically signiﬁcant differences in the use of services.
COPD/asthma co-occurring disease has higher utilization of any
service type than either disease alone. Compared with asthma,
COPD has higher use of hospitalizations (p < 0.0001), and less
out-patient services (p < 0.0001) and outpatient-emergency visits
(p < 0.0001). Logistic regression results suggest that COPD
patients were 16%-51% more likely to use physician visits (OR
= 1.16, 95% CI: 1.01–1.34) and inpatient services (OR = 1.51
95% CI: 1.31–1.74) and less likely to use out-patient services
(OR = 0.40 95% CI: 0.35–0.46). COPD and asthma co-occur-
ring patients had higher utilization of all services compared with
asthma patients. CONCLUSION: Our data suggest that COPD
and COPD/asthma co-occurring patients were sicker and used
more medical services than asthma patients.
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OBJECTIVES: To review the clinical outcomes of patients hos-
pitalized with chronic obstructive pulmonary disease (COPD)
acute exacerbations in Singapore and to describe the impact of
evidence-based management programs. METHODS: A retro-
spective review was designed for COPD exacerbations patients
admitted from year 2000 to 2005 in three public hospitals in 
Singapore. Adult patients aged 40 years and above with COPD
as the primary reason for hospitalization were retrieved from
computerized database. The outcomes studied included average
hospital length of stay (LOS), in-hospital mortality rate and read-
mission rates within 15 days, 30 days and 90 days. Univariate
ANOVA and Chi-square test, multivariate regression models and
trend analysis were applied to generate statistical results.
RESULTS: Among all 2996 COPD patients, 78.8% were male
(95% CI: 77.3–80.3%). Chinese were about 82.4% (95% C.I.:
81.0–83.8%), Indian 6.6% (95% CI: 5.7–7.5%), and Malay
7.8% (95% CI: 6.8–8.8%). Patients aged 60 and above were the
major population, taking up to 90.4% (95% CI: 89.3–91.5%).
From 2000 to 2005 there were signiﬁcant declines in LOS (6–3
days; p < 0.001), and mortality (12.1–3.7%; p < 0.001) rates.
There were also signiﬁcant reduction in readmission rates at 90
days (22.5–13.6%; p < 0.001) but not at 30 days (11.8–8.6%;
p = 0.076) or 15 days (6.5–6.0%; p = 0.218). By multivariate
regression, by controlling other factors, age is a risk factor for
longer hospital LOS (p = 0.02). Elder patients are also more dan-
gerous on in-hospital death (p < 0.001) and readmission within
90 days (p = 0.043). All the readmission rates for male patients
were signiﬁcantly higher than females (p = 0.002, p < 0.001 and
p < 0.001 for 15, 30, and 90 days respectively). CONCLUSION:
In summary, although the study suffers from several limitations,
i.e. lack of controls, confounded by disease severity etc, it has
shown that implementation of goal directed management pro-
grams in COPD patients was associated with positive trends in
reduced hospitalization, hospital mortality and readmission
rates.
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OBJECTIVES: The costs of respiratory tract infections are con-
siderable. The purpose of this study was to estimate the direct
